Georgia Theofan
Response Technologies (United States)(US)
Publications by Year
Research Areas
HIV Research and Treatment, Immune Response and Inflammation, Vitamin D Research Studies, HIV/AIDS drug development and treatment, Immune Cell Function and Interaction
Most-Cited Works
- → High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide(1992)260 cited
- → Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.(1992)228 cited
- → In vitro stimulation of germinal vesicle breakdown and ovulation of yellow perch (Perca flavescens) oocytes. Effects of 17α-hydroxy-20β-dihydroprogesterone and prostaglandins(1979)140 cited
- → Impact of Therapeutic Immunization on HIV‐1 Viremia after Discontinuation of Antiretroviral Therapy Initiated during Acute Infection(2005)114 cited
- → Regulation of calbindin-D28K gene expression by 1,25-dihydroxyvitamin D3 is correlated to receptor occupancy.(1986)112 cited
- → Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing protein(1994)93 cited
- → Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria(1994)89 cited
- → An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity.(1994)84 cited
- → A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis(2005)77 cited
- → Protective Effect of a Recombinant Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein in Experimental Endotoxemia(1993)73 cited